Item 2.02. Results of Operations and Financial Condition.

On July 29, 2020, United Therapeutics Corporation issued a press release setting forth its earnings for the quarter ended June 30, 2020.

A copy of the press release is attached hereto as Exhibit 99.1.

Item 9.01. Exhibits

This information shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.



(d)  Exhibits

Exhibit No.                             Description of Exhibit

     99.1         Press Release dated July 29, 2020
        104     The cover page from this Current Report on Form 8-K, formatted in
                Inline XBRL.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses